Roche Holding AG (ROP)
SIX
Real-time Data
07:00 AM
Day's Range
350.0052 wk Range
258.20Overview - ROP - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
303.03B
P/E (Trailing)
‪22.56‬
P/E (Forward)
‪15.77‬
PEG Ratio
‪15.77‬
Price / Sales (TTM)
‪4.37‬
Price / Book
‪8.42‬
EV / EBITDA
‪12.64‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
723.67M
Held by Insiders
‪0.00%‬
Held by Institutions
‪44.02%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪359.59‬
200-Day Avg
‪339.25‬
Dividends
Payout Ratio
‪63.93%‬
Frequency
Annual
Analyst Consensus
19 analysts
Average price target
‪CHF 370.31‬Market Cap - ROP - Roche Holding AG
Peers - ROP - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
Profile Summary - ROP - Roche Holding AG
About
Roche Holding AG is a Swiss healthcare holding company headquartered in Basel, overseeing one of the world’s largest integrated pharmaceuticals and diagnostics groups. The company operates today through two main divisions: Pharmaceuticals, which focuses on prescription medicines across oncology, immunology, infectious…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
